Brief: Herantis Pharma: Directed Share Issue Oversubscribed

Herantis Pharma Oyj

03/12/2019 06:59

Dec 3 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * REG-HERANTIS PHARMA PLC'S DIRECTED SHARE ISSUE IS
OVERSUBSCRIBED
MULTIPLE TIMES AND COMPLETED AS PLANNED
    * RAISES GROSS PROCEEDS OF APPROXIMATELY SEK 43.9 MLN IN
OFFERING​
    * AS THE OFFERING WAS OVERSUBSCRIBED MULTIPLE TIMES, BOARD
OF
DIRECTORS RESOLVED TO USE THE UPSIZE OPTION IN PRIVATE PLACEMENT
BY INCREASING NUMBER OF OFFER SHARES IN PRIVATE PLACEMENT BY
258,018 OFFER SHARES
    * SUBSCRIPTION PRICE FOR EACH OFFER SHARE WAS SEK 71 PER
OFFER
SHARE

Source text for Eikon:  ID:nGNE9328vl 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))